Olympus Pays Record Anti-Kickback Penalty For Device Case
This article was originally published in Clinica
Olympus Corp. is making a record payment and implementing stricter internal compliance controls and monitoring to avoid prosecution on kickback allegations.
You may also be interested in...
The finer points of when exactly the US government can collect from a device company for selling it a bill of goods are under reconsideration, even as the fast pace of False Claims Act suits continues, attorneys with law firm Gibson Dunn concluded during a series of recent webinars.
The US Department of Justice has announced resolution of 14 device-related investigations in 2016, including settlements, guilty pleas and a few executive convictions. The largest settlement this year, with Olympus Corp., accounted for almost three-quarters of the $825.5m total value of medtech fines in 2016.
Reimbursement efforts, individual liability and innovative corporate integrity agreements were among areas of focus at a recent Food and Drug Institute enforcement forum.